Drugs / Shenhuang Granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06514339 | Jul 2024 → Mar 2026 overdue | infectious disease with sepsis | The First Affiliated Hospital of Zhejiang Chinese Medical University | Recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shenhuang Granules | “Traditional Chinese medicine compound "Shenhuang Granules" is developed by Professor Fang Bangjiang” NCT06514339 ↗ |
| Known as | SHG | “Shenhuang Granules (SHG), composed of six ingredients:” PMID 41357500 ↗ Nov 2025 |
| Modality | Traditional medicine (herbal / TCM) | “Traditional Chinese medicine compound "Shenhuang Granules"” NCT06514339 ↗ |
| Route | Oral | “oral or nasal feeding (stomach tube or intestinal tube)” NCT06514339 ↗ |
| Route | Other | “oral or nasal feeding (stomach tube or intestinal tube)” NCT06514339 ↗ |